What is the recommended dose of Avil (pheniramine) for acute drug reactions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Avil (Pheniramine) for Acute Drug Reactions

For acute drug reactions including hypersensitivity reactions and dystonic reactions, administer pheniramine (Avil) at 1-2 mg/kg IV or IM, with a maximum initial dose of 50 mg. 1

Dosing Protocol

Adult Dosing

  • IV/IM route: 1-2 mg/kg per dose 1
  • Maximum initial dose: 50 mg 1
  • Oral route (when appropriate): 4-12 mg as a single nocturnal dose for ongoing allergic conditions 2

Pediatric Dosing

The dosing varies significantly by age group:

  • Children >12 years: 10 mg 2
  • Children 6 months to 6 years: 2.5 mg 2
  • Infants <6 months: 250 µg/kg 2

Administration Considerations

Route Selection

  • IV administration should be given slowly over 2-3 minutes to avoid pain at the injection site and reduce risk of seizures 1
  • IM route is acceptable when IV access is not immediately available 1
  • Rapid IV administration may precipitate seizures, so controlled infusion is critical 1

Role in Acute Reactions

Pheniramine serves as an adjunctive medication alongside epinephrine and hydrocortisone in managing anaphylactic reactions, not as primary therapy 2. It is indicated for acute hypersensitivity reactions and dystonic reactions as part of a comprehensive treatment approach 1.

Important Safety Considerations

Common Adverse Effects

  • Sedation is the most common side effect and should be anticipated 1, 2
  • Respiratory suppression may occur, particularly when combined with other sedative agents 1
  • Paradoxical excitement or agitation can develop, especially in younger children 1
  • Hypotension may occur, particularly with rapid administration 1

Contraindications and Precautions

  • Avoid in severe hepatic disease as sedative effects may precipitate hepatic coma 2
  • Contraindicated in angle-closure glaucoma, prostatic hypertrophy, and urinary retention 2, 3
  • Avoid concomitant use with MAOIs and medications with anticholinergic effects 2, 3
  • Consider dose reduction in moderate renal insufficiency (creatinine clearance 10-20 mL/min) 2, 3

Special Populations

  • Pregnancy: Should be avoided, especially during the first trimester, despite a long safety history 2, 3
  • Elderly patients: Start with lower doses due to increased sensitivity to anticholinergic effects 3
  • Lactation: Should be avoided 2

Clinical Pitfalls to Avoid

Monitoring Requirements

  • Monitor vital signs and oxygen saturation during and after administration 1
  • Be prepared to provide respiratory support, as there is increased risk of apnea when pheniramine is combined with other sedative agents 1
  • Watch for paradoxical agitation, particularly in pediatric patients 1

Drug Interactions

The anticholinergic effects are particularly problematic in elderly patients and those with severe hepatic disease 2. Avoid combining with other anticholinergic medications or MAOIs to prevent additive toxicity 2, 3.

Overdose Considerations

Pheniramine overdose can cause serious toxicity including antimuscarinic effects (dry mucous membranes, blurred vision, hallucinations), CNS excitation (irritability, insomnia, seizures), rhabdomyolysis, myoglobinuria, acute kidney injury, and rarely cardiotoxicity including ventricular tachycardia 4. Aggressive supportive therapy is essential in overdose situations 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clorfenamina: Uso Clínico y Precauciones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlorpheniramine Dosage and Precautions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.